Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07104097

Comparison Between 2 Techniques for Lumbar-ESPB

Regional Anesthesia in Hip Arthroplasty- Comparison Between Two Techniques for Erector Spinae Plane Block

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Papa Giovanni XXIII Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Diffusion of local anesthetics after a lumbar ESPB within fascial planes towards nerve structures is a matter of debate. The main objective of the study is to compare the incidence of sensory block between two techniques of needle placement (superficial or translaminar) during lumbar ESPB block. Patients are treated with lumbar ESPB (randomized to superficial or translaminar), spinal anesthesia and multimodal analgesia. The primary endpoint will be the incidence of numbness/reduced skin sensitivity to cold (ice test) in the area innervated by the lumbar plexus. Secondary outcomes are pain and analgesic's consumption, motor block, quality of recovery and discharge ability.

Conditions

Interventions

TypeNameDescription
PROCEDUREspinal anesthesiaspinal anesthesia at L3-L4 plain bupivacaine 0.5% 2.2 ml
PROCEDUREsuperficial erector spinal plane block (ESPB)Lidocaine 1% + ropivacaine 0.25% 30 ml with adrenaline 1:200.000 on top of L3 transverse process, between bone and erector spinae muscle
PROCEDUREdeep (inter laminar) erector spinal plane block (ESPB)Lidocaine 1% + ropivacaine 0.25% 30 ml with adrenaline 1:200.000 between L3 and L4 transverse process, between erector spinae muscle and deep muscles
DRUGDexamethasone8 mg iv preoperatively
DRUGIbuprofen 400 mgpreoperatively and postoperatively (every 8 hours)
DRUGParacetamol1000 mg preoperatively and postoperatively (every 8 hours)
DRUGMorphinePatient Controlled Analgesia

Timeline

Start date
2025-08-11
Primary completion
2026-06-20
Completion
2026-06-20
First posted
2025-08-05
Last updated
2025-08-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07104097. Inclusion in this directory is not an endorsement.